9 Cathie Wood 10x Genomics Trades
Cathie Wood's position in 10x Genomics is currently worth $102 Million. That's 0.75% of their equity portfolio (30th largest holding). The investor owns 3.59% of the outstanding 10x Genomics stock. The first 10x Genomics trade was made in Q2 2020. Since then Cathie Wood bought shares five more times and sold shares on three occasions. The investor's estimated purchase price is $540 Million, resulting in a loss of 81%.
Avg closing price
Price range
Increased shares by 6.2% (+212 Thousand shares)
Q2 2022
Avg closing price
$51.88
Price range
$36.95
-
$82.41
Increased shares by 27.5% (+730 Thousand shares)
Q1 2022
Avg closing price
$87.48
Price range
$55.70
-
$145.79
Sold 14.2% shares (-441 Thousand shares)
Q4 2021
Avg closing price
$153.17
Price range
$135.05
-
$182.59
Sold 27.9% shares (-1.2 Million shares)
Q3 2021
Avg closing price
$171.69
Price range
$145.58
-
$192.14
Increased shares by 22.7% (+796 Thousand shares)
Q2 2021
Avg closing price
$180.98
Price range
$134.22
-
$202.37
Increased shares by 556.8% (+2.97 Million shares)
Q1 2021
Avg closing price
$172.69
Price range
$140.25
-
$196.86
Increased shares by 130.9% (+302 Thousand shares)
Q4 2020
Avg closing price
$145.11
Price range
$126.47
-
$163.70
Sold 31.3% shares (-105 Thousand shares)
Q3 2020
Avg closing price
$104.97
Price range
$87.44
-
$125.00
New holding (+337 Thousand shares)
Q2 2020
Avg closing price
$77.89
Price range
$58.39
-
$89.31
